Although the pathogenic role of CD4+CD28null T lymphocytes in RA has not been yet firmly established and further research is necessary, these genes and proteins could be investigated as possible therapeutic targets for RA in future research. This evidence concerns the gene CD4 and rheumatoid arthritis.